Jump to content

EU Experts Back Roche's Avastin in Lung Cancer


Recommended Posts

http://www.reuters.com/article/health-S ... 1720070719

LONDON, July 19 (Reuters) - Swiss drugmaker Roche Holding AG's (ROG.VX: Quote, Profile, Research)

Avastin medicine has been recommended for approval in non-small cell lung cancer, the European Medicines Agency said on Thursday.

Recommendations for marketing approval by the agency's Committee for Medicinal Products for Human Use are normally endorsed by the European Commission within a couple of months.

Avastin is the first in a class of drugs that seek to starve tumours of their blood and nutrients. It had global sales of about $2.5 billion in 2006 and Roche and U.S. partner Genentech Inc. (DNA.N: Quote, Profile, Research) hope expanded uses will boost the franchise.

Avastin has already been approved in lung cancer in the United States.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use. We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.